- Mutual Funds
- WhiteOak Capital Mutual Fund
- WhiteOak Capital Pharma and Healthcare Fund Direct Growth
WhiteOak Capital Pharma and Healthcare Fund Direct Plan Growth
₹ 12.28
NAV (Apr 09)
19.151%
Till Date CAGR
Scripbox Opinion
Not Reviewed yet
Our analysis of this fundLearn how we rate funds ->
View Less
Scripbox Recommended Equity Funds 
Want the equity funds that are right for your long term equity investment needs?Learn more
Scheme Information
Investment Objective
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Expense Ratio | 0.55 % |
Launched 1Y ago | 2024-02-06 |
AUM in Crores | 303.6 |
ISIN | INF03VN01886 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation | - |
Beta | - |
Sharpe Ratio | - |
Fund Managers
Asset allocation and Holdings
Top Stock Holdings
Others
8.31%Sun Pharmaceutical Industries Ltd.
7.03%Sun Pharmaceutical Industries Ltd.
5.69%Zydus Lifesciences Ltd.
5.36%Divi's Laboratories Ltd.
4.97%See all holdings
Allocation by Sector
Healthcare
97.07%Chemicals
1.14%Diversified
0.57%Materials
0.45%See all sectors
Comparison with Equity Funds
| Fund Name | Fund Size | |
|---|---|---|
₹ 49,131 cr | ||
₹ 93,440 cr | ||
₹ 64,962 cr | ||
₹ 16,217 cr | ||
₹ 27,730 cr |
Frequently Asked Questions
Loading...